Radiotherapy Plus Chemoimmunotherapy Improves Frontline ES-SCLC Prognosis | CancerNetwork
Radiotherapy Plus Chemoimmunotherapy Enhances Frontline ES-SCLC Outcomes Combining anti-angiogenic therapy with chemoimmunotherapy is increasingly considered for real-world treatment of e…